RUA Life Sciences plc is a holding company of the group trading through four businesses, including RUA Medical Devices, RUA Vascular, RUA Biomaterials, and RUA Structural Heart. The company's vision is to improve the lives of millions of patients by enabling medical devices with Elast-Eon, the world's leading long-term implantable polyurethane. Whether it's licensing Elast-Eon, manufacturing a device or component, or developing next-generation medical devices, a RUA Life Sciences business is dedicated to pursuing this vision. Founded in 2020 and headquartered in the United Kingdom, the company is positioned to make a significant impact in the medical devices industry. With a focus on enabling medical devices with innovative technology, RUA Life Sciences is well-positioned to make waves in the industry. Currently, there is no available information regarding the last investment or the investors involved.
There is no investment information
No recent news or press coverage available for RUA Life Sciences plc.